TET2 and myelodysplastic syndrome: Further complicating matters is the finding that these methylation patterns do not appear to correlate well with gene expression changes in AML and MDS samples, while mutations in both TET2 and DNMT3A clearly have prognostic implications and participate in leukemogenesis.